Skip to main content
SpringerLink
Log in

Health-related (HR) QOL showed little or moderate improvement in younger patients treated with fludarabine

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Eichhorst BF, Busch R, Obwandner T, Kuhn-Hallek I, Herschbach P, Hallek M.Health-related quality of life in younger patients with chronic lymphocytic leukemia treated with fludarabine plus cyclophosphamide or fludarabine alone for first-line therapy: a study by the German CLL Study Group. Journal of Clinical Oncology 25: 1722-1731, No. 13, 1 May 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Health-related (HR) QOL showed little or moderate improvement in younger patients treated with fludarabine. Pharmacoecon. Outcomes News 527, 9 (2007). https://doi.org/10.1007/BF03309423

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03309423

Keywords

Search

Navigation